omega-n-methylarginine has been researched along with pravastatin in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pravastatin) | Trials (pravastatin) | Recent Studies (post-2010) (pravastatin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 3,575 | 1,036 | 816 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | pravastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.1452 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0056 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0056 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0254 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, K; Eshima, K; Hironaga, K; Hirooka, Y; Masumoto, A; Setoguchi, S; Takeshita, A | 1 |
| Bayerle-Eder, M; Bischof, MG; Fuchsjäger-Mayrl, G; Polska, E; Roden, M; Schmetterer, L; Sieder, A; Stulnig, T; Waldhäusl, W; Wolzt, M | 1 |
2 trial(s) available for omega-n-methylarginine and pravastatin
| Article | Year |
|---|---|
Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).
Topics: Acetylcholine; Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pravastatin; Vasodilation; Vasodilator Agents | 2001 |
Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia.
Topics: Australia; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Kidney; Male; Middle Aged; omega-N-Methylarginine; Pravastatin; Time Factors; Triglycerides | 2002 |